165 related articles for article (PubMed ID: 35053528)
1. Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism.
Siech C; Rutz J; Maxeiner S; Grein T; Sonnenburg M; Tsaur I; Chun FK; Blaheta RA
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053528
[TBL] [Abstract][Full Text] [Related]
2. Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells.
Juratli MA; Zhou H; Oppermann E; Bechstein WO; Pascher A; Chun FK; Juengel E; Rutz J; Blaheta RA
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626034
[TBL] [Abstract][Full Text] [Related]
3. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
4. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.
Tsaur I; Makarević J; Juengel E; Gasser M; Waaga-Gasser AM; Kurosch M; Reiter M; Wedel S; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Br J Cancer; 2012 Aug; 107(5):847-55. PubMed ID: 22782340
[TBL] [Abstract][Full Text] [Related]
5. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
[TBL] [Abstract][Full Text] [Related]
6. IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels.
Sayeed A; Fedele C; Trerotola M; Ganguly KK; Languino LR
PLoS One; 2013; 8(10):e76513. PubMed ID: 24130778
[TBL] [Abstract][Full Text] [Related]
7. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
8. [Effect of epidermal growth factor signal pathway on integrin alpha5 beta1 in prostate cancer cell line DU145].
Chen HJ; Wang H; Wang QY; Zhang L; Wang GM
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(14):966-9. PubMed ID: 17074207
[TBL] [Abstract][Full Text] [Related]
9. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.
Lee YC; Jin JK; Cheng CJ; Huang CF; Song JH; Huang M; Brown WS; Zhang S; Yu-Lee LY; Yeh ET; McIntyre BW; Logothetis CJ; Gallick GE; Lin SH
Mol Cancer Res; 2013 Apr; 11(4):405-17. PubMed ID: 23339185
[TBL] [Abstract][Full Text] [Related]
10. HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression.
Makarević J; Rutz J; Juengel E; Maxeiner S; Mani J; Vallo S; Tsaur I; Roos F; Chun FK; Blaheta RA
Cells; 2018 Sep; 7(9):. PubMed ID: 30200497
[TBL] [Abstract][Full Text] [Related]
11. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.
Jones JI; Prevette T; Gockerman A; Clemmons DR
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2482-7. PubMed ID: 8637900
[TBL] [Abstract][Full Text] [Related]
12. The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability.
Benelli R; Monteghirfo S; Venè R; Tosetti F; Ferrari N
Mol Cancer; 2010 Jun; 9():142. PubMed ID: 20537156
[TBL] [Abstract][Full Text] [Related]
13. Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation.
Zheng DQ; Woodard AS; Tallini G; Languino LR
J Biol Chem; 2000 Aug; 275(32):24565-74. PubMed ID: 10835423
[TBL] [Abstract][Full Text] [Related]
14. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor.
Shakibaei M; John T; De Souza P; Rahmanzadeh R; Merker HJ
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):615-23. PubMed ID: 10477272
[TBL] [Abstract][Full Text] [Related]
16. Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
Makarević J; Rutz J; Juengel E; Kaulfuss S; Tsaur I; Nelson K; Pfitzenmaier J; Haferkamp A; Blaheta RA
PLoS One; 2014; 9(10):e110244. PubMed ID: 25333694
[TBL] [Abstract][Full Text] [Related]
17. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.
DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR
J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Waaga-Gasser A; Haferkamp A; Blaheta RA
BMC Cancer; 2011 Aug; 11():375. PubMed ID: 21867506
[TBL] [Abstract][Full Text] [Related]
19. Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells.
Yang Y; Wang Y; Che X; Hou K; Wu J; Zheng C; Cheng Y; Liu Y; Hu X; Zhang J
Oncol Lett; 2021 Jul; 22(1):556. PubMed ID: 34084223
[TBL] [Abstract][Full Text] [Related]
20. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
